Intellipharmaceutics International Inc. (IPCI)

[numbersarefun]

Biovail's fortune tied mostly to Wellbutrin XL. I just found this out. I looked up Biovail's product page from 2010 in archive.org's time machine. I think Biovail partnered with GlaxoSmithKline to develop Wellbutrin XL. I think Wellbutrin XL reached blockbuster drug status, with over a billion dollars sales a year. Biovail maybe had another moderately successful drug in Cardizem LA in United States and Tiazac XC in Canada.

While IPCI might have mild success with there NDA products, such as Rexista and Pregabatin, it is very difficult to come up with a blockbuster drug. So I would be skeptical that IPCI can duplicate Biovail's success.

A Wellbutrin XL type of deal would be if IPCI and Pfizer partnered for Lyrica XR, using IPCI's version of the drug. Wellbutrin XL was the extended-release version when Wellbutrin immediate-release was coming off-patent. In a few years, immediate-release Lyrica is coming off-patent. That is why Pfizer is developing extended-release Lyrica, so I doubt Pfizer would want to partner with IPCI.

ImpactTrader16 wrote: "he will build IPCI to be the next Biogen."